ID   OnyCap-23
AC   CVCL_IQ34
SY   Onycap-23; ONYCAP-23; Onycap23; ONYCAP23; Ony-Cap 23
DR   Wikidata; Q54936434
RX   Patent=US7303911;
CC   Group: Patented cell line.
CC   From: Onyvax, Ltd; London; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032801.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4889 ! PNT2-C2
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
RX   Patent=US7303911;
RA   Thraves P.J., Sutton A.;
RT   "Prostate cell lines.";
RL   Patent number US7303911, 04-Dec-2007.
//